Fig. 4From: Cost-effectiveness analysis of CTZ/TAZ for the treatment of ventilated hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia in JapanAcceptability curve for CTZ/TAZ versus MEPMCTZ/TAZ = ceftolozane/tazobactam, MEPM = MeropenemBack to article page